Industry Pipeline - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industry Pipeline
Pre-Interphex 2010 Product Releases.

Pharmaceutical Technology
Volume 34, Issue 3, pp. 83-87



Drug-delivery solutions
For more than 50 years, companies have looked to 3M Drug Delivery Systems for solutions to help their products meet the market's needs. 3M offers inhalation and transdermal drug-delivery systems and components, including dry-powder inhaler and microneedle technologies, plus state-of-the-art contract manufacturing services to help ensure technical success. 3M Drug Delivery Systems, St. Paul, MN http://www.3m.com/ tel. 800.643.8086



Analytical pharmaceutical services
AAIPharma takes a customer-focused approach to solving drug-development and manufacturing challenges. The company's analytical pharmaceutical services include clinical packaging and distribution, sterile and solid-dose manufacturing, analytical services, validation, regulatory-affairs consulting, formulation development, and oral drug-delivery technologies. AAIPharma, Wilmington, NC http://www.aaipharma.com/ tel. 910.254.7000



Virology consulting services
Compliance Insight offers virology consulting services for biological pharmaceuticals and devices. Clients can benefit from various design and review services for viral clearance and cleaning validation, raw-materials testing, product-lot release testing, and product risk assessments for viral contamination. Compliance Insight, Fairfield, OH http://www.compliance-insight.com/ tel. 513.860.3512



Contract manufacturing
Cangene bioPharma (formerly Chesapeake Biological Laboratories) offers contract manufacturing for the aseptic fill–finish of liquid and lyophilized sterile injectables into vials and syringes. Cangene provides clinical- and commercial-scale manufacturing, and its clients distribute their products worldwide. Cangene's sites have received approvals from US, European, and Japanese regulatory authorities. Cangene bioPharma, Baltimore, MD http://www.cblinc.com/ tel. 800.441.4225



Analytical pharmaceutical services
AAIPharma takes a customer-focused approach to solving drug-development and manufacturing challenges. The company's analytical pharmaceutical services include clinical packaging and distribution, sterile and solid-dose manufacturing, analytical services, validation, regulatory-affairs consulting, formulation development, and oral drug-delivery technologies. AAIPharma, Wilmington, NC http://www.aaipharma.com/ tel. 910.254.7000


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
19%
To all process for new products only
14%
To select process for new products only
24%
To select processes for both new and legacy products
19%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here